Today it is possible to use DNA sequencing to improve prognostication and predict treatment response in patients with the most common form of leukemia; chronic lymphocytic leukemia. New results from a research group lead by SciLifeLab faculty member Richard Rosenquist Brandell shows that next-generation sequencing technology can provide equally reliable results as previous methods. The new technique could thus be used routinely for prognostication in chronic lymphocytic leukemia.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.